基本信息
views: 4
Career Trajectory
Bio
His basic and translational research focus on the development of novel therapeutic approach in cancer treatment through identifying potential targets and understanding the fundamental biology of cancer cell. Professor Tse has pioneered the development of intracellular antibodies in the therapy of cancer during his early stage of career. He is currently examining the role of peptidyl-prolyl-isomerase PIN1 and investigating the therapeutic potential of arsenic trioxide in cancers. In addition to his laboratory work, Professor Tse is also active in clinical research on lymphoid neoplasms and cancer-associated thrombosis.
Research Interests
Papers共 220 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal of Thrombosis and Thrombolysisno. 2 (2024): 312-321
CHEMICAL SCIENCEno. 27 (2024): 10264-10280
Philipp Huettemann, Pavithra Mahadevan,Justine Lempart,Eric Tse, Budheswar Dehury,Brian F. P. Edwards,Daniel R. Southworth,Bikash R. Sahoo,Ursula Jakob
bioRxiv the preprint server for biology (2024)
Bone Marrow Transplantationno. 5 (2024): 1-10
Cancer Researchno. 6_Supplement (2024): 3910-3910
Clinical Lymphoma Myeloma and Leukemia (2024)
Ujjayini Ghosh,Eric Tse,Hyunjun Yang,Marie Shi, Christoffer D Carlo, Feng Wang,Gregory E Merz,Stanley B Prusiner,Daniel R Southworth,Carlo Condello
bioRxiv : the preprint server for biologyno. 1 (2024): 1-15
Nature structural & molecular biologyno. 12 (2023): 2009-2019
Cited0Views0Bibtex
0
0
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn